How much does Cytoplan Limited make?

Cytoplan Limited reported revenue of £11.8m and £1.6m profit in the year to 31 Aug 2025, according to its accounts filed at Companies House.

How many employees does Cytoplan Limited have?

Cytoplan Limited reported an average of 51 employees in the year to 31 Aug 2025.

Is Cytoplan Limited profitable?

Yes — Cytoplan Limited reported a profit of £1.6m in the year to 31 Aug 2025.

Company No. 01493205 · Incorporated 24 Apr 1980

Cytoplan Limited

Registered name: CYTOPLAN LIMITED

Part of The Nutritional Wellbeing Foundation group

Cytoplan Limited made £11.8m revenue and £1.6m profit in the year to 31 Aug 2025.

Cytoplan Limited’s revenue grew 11% to £11.8m in the year to 31 Aug 2025, with £1.6m profit and 51 employees. The company is classified under “wholesale of pharmaceutical goods” and is based in Worcester; we hold 4 years of its filed accounts.

Full P&L filedSection G · Wholesale and retail trade; repair of motor vehiclesSIC 46460Wholesale of pharmaceutical goods

Status: Active
Location: Worcester, West Midlands
Age: 46 yrs · since 1980
Type: Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently. From the filing: “Nutritional Wellbeing Foundation”

Latest accounts · year to 31 Aug 2025

Key figures

Operating leverageCash flow filed

Revenue

£11.8m

Growth ▲10.7%

Profit

£1.6m

Growth ▲71%

Profit margin

14%

Gross 62%

Employees

Change ▲4.1%

Profit / employee

£32.3k

Revenue/employee £232k

Profitable streak

4yrs

Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

4 filed years

Financial history

Multi-year financials, oldest to newest
Year to	31 Aug 2022	31 Aug 2023	31 Aug 2024	31 Aug 2025
Disclosure	Profit only	Profit only	Full P&L	Full P&L
Profit & loss
Revenue (turnover)	—	—	£10.7m	£11.8m
Cost of sales	—	—	£4.5m	£4.5m
Gross profit	—	—	£6.2m	£7.3m
Operating profit	—	—	£1m	£1.8m
Profit before tax	—	—	£1.1m	£1.8m
Profit after tax	£993k	£1.1m	£964k	£1.6m
Profit (best available)	£993k	£1.1m	£964k	£1.6m
Staff costs	—	—	£2.2m	£2.3m
Employees (average)	49	48	49	51
Ratios
Profit margin	—	—	9%	14%
Gross margin	—	—	57.9%	62%
Revenue per employee	—	—	£218k	£232k
Profit per employee	£20.3k	£22.1k	£19.7k	£32.3k
Cash conversion	—	—	196.5%	90.1%
Growth (year on year)
Revenue growth	—	—	—	▲10.7%
Profit growth	—	▲6.6%	▼8.9%	▲71%
Headcount growth	—	▼2%	▲2.1%	▲4.1%
Balance sheet — indirect signals, not revenue
Cash at bank	£2.2m	£4.3m	£1.4m	£2.1m
Net assets	£4.6m	£5.2m	£5.7m	£6.7m
Fixed assets	£597k	£458k	£4.4m	£4.6m
Current assets	£5.7m	£6.8m	£3.4m	£4.3m
Debtors	£198k	£213k	£238k	£514k
Cash from operations	—	—	£2m	£1.6m
Source	FullAccounts · bulk data Apr 2024	FullAccounts · bulk data Apr 2024	FullAccounts · bulk data May 2025	FullAccounts · bulk data Jun 2026

Derived from the latest filing

How the business works

Profit margin: 14%; Profit ÷ revenue.
Gross margin: 62%; Gross profit ÷ revenue. High for software and services.
Revenue per employee: £232k; Revenue ÷ average employees.
Profit per employee: £32.3k; Profit ÷ average employees.
Cash conversion: 90.1%; Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue: 38.7%; Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue: —; Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue: 4.4%; Money owed by customers. Low = customers pay quickly.

Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets: ▲18%; Now £6.7m
Cash at bank: ▲48%; Now £2.1m
Headcount: ▲4%; Now 51
Deferred income: —; Now —
Fixed assets: ▲4%; Now £4.6m

Corporate ownership

Group structure

Ownership chain

The Nutritional Wellbeing Foundation (registered outside the UK register)ultimate parent75–100%
Cytoplan Limitedthis company

Bands show the share of ownership each company holds in the one below it.

Subsidiaries (3)

Biogrow LimitedFigures not disclosed
Malvern Pharmaceutical Supplies LimitedFigures not disclosed
Nature's Own LimitedFigures not disclosed

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Companies House profile Filing history & original accounts

Latest figures from FullAccounts for the year to 31 Aug 2025 (profit £1.6m), from the Companies House accounts bulk data published Jun 2026. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.